| 摘要 |
<p>The invention provides canine CD20 nucleotide and protein sequences. These compositions are useful in the diagnosis and treatment of e.g., CD20+ B-cell lymphoma, immune-mediated hemolytic anemia, immune-mediated thrombocytopenia, and systemic lupus erythematosus (SLE) in canines and felines.</p> |
